The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hemostat Powder Market Research Report 2025
Synopsis
When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding.
Hemostat powder is product in form of powder.
The global Hemostat Powder market was valued at US$ 386.4 million in 2023 and is anticipated to reach US$ 531.4 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
Market competition is intense. Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring and Gelita Medical, etc. are the leaders of the industry, with about 70% market shares.
North America is the largest consumption place, with a consumption market share nearly 40%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
The classification of hemostat powder includes gelatin, fibrin, cellulose and the proportion of gelatin is about 38%.
Hemostat Powder is widely used in surgical wound care and general wound care. The most proportion of hemostat powder is used in surgical wound care, and the proportion is 65%.
This report aims to provide a comprehensive presentation of the global market for Hemostat Powder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostat Powder.
Report Scope
The Hemostat Powder market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemostat Powder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostat Powder manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
C. R. Bard
Pfizer
CSL Behring
Gelita Medical
Ferrosan Medical Devices
Baxter
Celox
Equimedical
Medira
Biocer
Hemostasis
MBP
Segment by Type
Gelatin
Fibrin
Cellulose
Others
Segment by Application
Surgical Wound Care
General Wound Care
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemostat Powder manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemostat Powder in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding.
Hemostat powder is product in form of powder.
The global Hemostat Powder market was valued at US$ 386.4 million in 2023 and is anticipated to reach US$ 531.4 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
Market competition is intense. Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring and Gelita Medical, etc. are the leaders of the industry, with about 70% market shares.
North America is the largest consumption place, with a consumption market share nearly 40%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
The classification of hemostat powder includes gelatin, fibrin, cellulose and the proportion of gelatin is about 38%.
Hemostat Powder is widely used in surgical wound care and general wound care. The most proportion of hemostat powder is used in surgical wound care, and the proportion is 65%.
This report aims to provide a comprehensive presentation of the global market for Hemostat Powder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostat Powder.
Report Scope
The Hemostat Powder market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemostat Powder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostat Powder manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
C. R. Bard
Pfizer
CSL Behring
Gelita Medical
Ferrosan Medical Devices
Baxter
Celox
Equimedical
Medira
Biocer
Hemostasis
MBP
Segment by Type
Gelatin
Fibrin
Cellulose
Others
Segment by Application
Surgical Wound Care
General Wound Care
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemostat Powder manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemostat Powder in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Hemostat Powder Market Overview
1.1 Product Overview and Scope of Hemostat Powder
1.2 Hemostat Powder Segment by Type
1.2.1 Global Hemostat Powder Market Value Comparison by Type (2024-2030)
1.2.2 Gelatin
1.2.3 Fibrin
1.2.4 Cellulose
1.2.5 Others
1.3 Hemostat Powder Segment by Application
1.3.1 Global Hemostat Powder Market Value by Application: (2024-2030)
1.3.2 Surgical Wound Care
1.3.3 General Wound Care
1.4 Global Hemostat Powder Market Size Estimates and Forecasts
1.4.1 Global Hemostat Powder Revenue 2019-2030
1.4.2 Global Hemostat Powder Sales 2019-2030
1.4.3 Global Hemostat Powder Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hemostat Powder Market Competition by Manufacturers
2.1 Global Hemostat Powder Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hemostat Powder Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hemostat Powder Average Price by Manufacturers (2019-2024)
2.4 Global Hemostat Powder Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hemostat Powder, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hemostat Powder, Product Type & Application
2.7 Hemostat Powder Market Competitive Situation and Trends
2.7.1 Hemostat Powder Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hemostat Powder Players Market Share by Revenue
2.7.3 Global Hemostat Powder Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hemostat Powder Retrospective Market Scenario by Region
3.1 Global Hemostat Powder Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hemostat Powder Global Hemostat Powder Sales by Region: 2019-2030
3.2.1 Global Hemostat Powder Sales by Region: 2019-2024
3.2.2 Global Hemostat Powder Sales by Region: 2025-2030
3.3 Global Hemostat Powder Global Hemostat Powder Revenue by Region: 2019-2030
3.3.1 Global Hemostat Powder Revenue by Region: 2019-2024
3.3.2 Global Hemostat Powder Revenue by Region: 2025-2030
3.4 North America Hemostat Powder Market Facts & Figures by Country
3.4.1 North America Hemostat Powder Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hemostat Powder Sales by Country (2019-2030)
3.4.3 North America Hemostat Powder Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemostat Powder Market Facts & Figures by Country
3.5.1 Europe Hemostat Powder Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hemostat Powder Sales by Country (2019-2030)
3.5.3 Europe Hemostat Powder Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemostat Powder Market Facts & Figures by Country
3.6.1 Asia Pacific Hemostat Powder Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hemostat Powder Sales by Country (2019-2030)
3.6.3 Asia Pacific Hemostat Powder Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hemostat Powder Market Facts & Figures by Country
3.7.1 Latin America Hemostat Powder Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hemostat Powder Sales by Country (2019-2030)
3.7.3 Latin America Hemostat Powder Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemostat Powder Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemostat Powder Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hemostat Powder Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hemostat Powder Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Hemostat Powder Sales by Type (2019-2030)
4.1.1 Global Hemostat Powder Sales by Type (2019-2024)
4.1.2 Global Hemostat Powder Sales by Type (2025-2030)
4.1.3 Global Hemostat Powder Sales Market Share by Type (2019-2030)
4.2 Global Hemostat Powder Revenue by Type (2019-2030)
4.2.1 Global Hemostat Powder Revenue by Type (2019-2024)
4.2.2 Global Hemostat Powder Revenue by Type (2025-2030)
4.2.3 Global Hemostat Powder Revenue Market Share by Type (2019-2030)
4.3 Global Hemostat Powder Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hemostat Powder Sales by Application (2019-2030)
5.1.1 Global Hemostat Powder Sales by Application (2019-2024)
5.1.2 Global Hemostat Powder Sales by Application (2025-2030)
5.1.3 Global Hemostat Powder Sales Market Share by Application (2019-2030)
5.2 Global Hemostat Powder Revenue by Application (2019-2030)
5.2.1 Global Hemostat Powder Revenue by Application (2019-2024)
5.2.2 Global Hemostat Powder Revenue by Application (2025-2030)
5.2.3 Global Hemostat Powder Revenue Market Share by Application (2019-2030)
5.3 Global Hemostat Powder Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson & Johnson Hemostat Powder Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 C. R. Bard
6.2.1 C. R. Bard Corporation Information
6.2.2 C. R. Bard Description and Business Overview
6.2.3 C. R. Bard Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.2.4 C. R. Bard Hemostat Powder Product Portfolio
6.2.5 C. R. Bard Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Hemostat Powder Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 CSL Behring
6.4.1 CSL Behring Corporation Information
6.4.2 CSL Behring Description and Business Overview
6.4.3 CSL Behring Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CSL Behring Hemostat Powder Product Portfolio
6.4.5 CSL Behring Recent Developments/Updates
6.5 Gelita Medical
6.5.1 Gelita Medical Corporation Information
6.5.2 Gelita Medical Description and Business Overview
6.5.3 Gelita Medical Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Gelita Medical Hemostat Powder Product Portfolio
6.5.5 Gelita Medical Recent Developments/Updates
6.6 Ferrosan Medical Devices
6.6.1 Ferrosan Medical Devices Corporation Information
6.6.2 Ferrosan Medical Devices Description and Business Overview
6.6.3 Ferrosan Medical Devices Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ferrosan Medical Devices Hemostat Powder Product Portfolio
6.6.5 Ferrosan Medical Devices Recent Developments/Updates
6.7 Baxter
6.6.1 Baxter Corporation Information
6.6.2 Baxter Description and Business Overview
6.6.3 Baxter Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Baxter Hemostat Powder Product Portfolio
6.7.5 Baxter Recent Developments/Updates
6.8 Celox
6.8.1 Celox Corporation Information
6.8.2 Celox Description and Business Overview
6.8.3 Celox Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Celox Hemostat Powder Product Portfolio
6.8.5 Celox Recent Developments/Updates
6.9 Equimedical
6.9.1 Equimedical Corporation Information
6.9.2 Equimedical Description and Business Overview
6.9.3 Equimedical Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Equimedical Hemostat Powder Product Portfolio
6.9.5 Equimedical Recent Developments/Updates
6.10 Medira
6.10.1 Medira Corporation Information
6.10.2 Medira Description and Business Overview
6.10.3 Medira Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Medira Hemostat Powder Product Portfolio
6.10.5 Medira Recent Developments/Updates
6.11 Biocer
6.11.1 Biocer Corporation Information
6.11.2 Biocer Hemostat Powder Description and Business Overview
6.11.3 Biocer Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Biocer Hemostat Powder Product Portfolio
6.11.5 Biocer Recent Developments/Updates
6.12 Hemostasis
6.12.1 Hemostasis Corporation Information
6.12.2 Hemostasis Hemostat Powder Description and Business Overview
6.12.3 Hemostasis Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Hemostasis Hemostat Powder Product Portfolio
6.12.5 Hemostasis Recent Developments/Updates
6.13 MBP
6.13.1 MBP Corporation Information
6.13.2 MBP Hemostat Powder Description and Business Overview
6.13.3 MBP Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.13.4 MBP Hemostat Powder Product Portfolio
6.13.5 MBP Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemostat Powder Industry Chain Analysis
7.2 Hemostat Powder Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemostat Powder Production Mode & Process
7.4 Hemostat Powder Sales and Marketing
7.4.1 Hemostat Powder Sales Channels
7.4.2 Hemostat Powder Distributors
7.5 Hemostat Powder Customers
8 Hemostat Powder Market Dynamics
8.1 Hemostat Powder Industry Trends
8.2 Hemostat Powder Market Drivers
8.3 Hemostat Powder Market Challenges
8.4 Hemostat Powder Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
